Grip strength in patients with galactosemia and in a galactose‐1‐phosphate uridylyltransferase (GALT)‐null rat model

Racial and ethnic diversity of classic and clinical variant galactosemia in the United States

(2023) Nichole M. Stettner et al.   MOLECULAR GENETICS AND METABOLISM

The natural history of classic galactosemia: lessons from the GalNet registry

(2019) M. E. Rubio-Gozalbo et al.   Orphanet Journal of Rare Diseases

Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia

(2017) Elena Conte et al.   Journal of Cachexia Sarcopenia and Muscle

International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up

(2016) Lindsey Welling et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Modifiers of Ovarian Function in Girls and Women With Classic Galactosemia

(2013) Jessica B. Spencer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cryptic residual GALT activity is a potential modifier of scholastic outcome in school age children with classic galactosemia

(2013) Emily L. Ryan et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Movement Disorders in Adult Patients With Classical Galactosemia

(2013) Ignacio Rubio-Agusti et al.   MOVEMENT DISORDERS